Embolic Protection Devices Market Exclusive Report with Detailed Study Analysis

The market size of the global embolic protection devices market in the year 2024 is valued at 640.50 million and is predicted to reach 2458.23 million by the year 2034 at an 7.4% CAGR during the forecast period.

Stenting plays a crucial role in reducing distal embolization by utilizing embolic protection devices (EPDs), which capture blood and luminal particles within the saphenous vein graft (SVG). These devices provide a reliable, evidence-based approach to minimizing major adverse cardiovascular events (MACE) and periprocedural myocardial infarctions (MI) during SVG procedures. Designed to capture and remove debris generated during interventions, EPDs help prevent plaque particles from entering the distal vasculature, thereby improving clinical outcomes.

The growing preference for minimally invasive procedures is expected to drive the expansion of the embolic protection devices market. The use of EPDs in percutaneous cardiac interventions has significantly reduced complications associated with debris entering the bloodstream and obstructing smaller capillaries. This increased demand for advanced embolic protection solutions is anticipated to further accelerate market growth.

Get A Free Report Brochure:
https://www.insightaceanalytic.com/request-sample/1454

The increase in the population of older people is a crucial factor contributing to the market's growth. Additionally, rising healthcare costs and technological innovation are the main factors that will accelerate market expansion. The prevalence of cardiovascular and neurovascular illnesses is also expected to benefit the market's growth rate. On the other hand, substantial R&D expenditures and a rise in product failure and recall rates will restrain market expansion. Additionally, a rigorous regulatory environment and unfavourable government regulations will pose a hurdle to the market for embolic protection devices.

Market Segmentation:
The embolic protection devices market is segmented on the product, application, material and end-use. Based on the product, the market is segmented into distal occlusion systems, distal filters and proximal occlusion systems. Based on application, the embolic protection devices market is segmented into neurovascular disease, cardiovascular disease and peripheral disease. Based on the material, the embolic protection devices market is segmented into nitinol and polyurethane. Based on the end-user, the embolic protection devices market is segmented into ambulatory surgical centres, hospitals and others.

Based on product, the distal filters segment is accounted as a significant contributor to the embolic protection devices market.
Based on the product, the market is segmented into distal occlusion systems, distal filters and proximal occlusion systems. The distal filters category grabbed the highest revenue share, and it is anticipated that they will continue to hold that position during the anticipated time attributed to the procedural advantages distal filter devices provide, including user comfort, enhanced visibility, and the device's crossing profile. In addition to the device's benefits, the global rise in the prevalence of cardiovascular and neurovascular disorders has further encouraged the segment's growth.

According to the American Heart Association, almost 801,000 deaths in the United States are attributed to cardiovascular disease (CVD), accounting for around one in three fatalities in the nation. About 2,200 Americans every day, or one every 40 seconds, pass away from cardiovascular disease. According to statistics, the growing patient base leads to an increase in angioplasty operations and surgeries that call for an embolic prevention device, which drives the segment's expansion.
The cardiovascular disease segment witnessed growth at a rapid rate.

Based on application, the embolic protection devices market is segmented into neurovascular disease, cardiovascular disease and peripheral disease. The cardiovascular disease category is anticipated to grow significantly over the forecast period. Cardiovascular operations primarily involve embolic protection devices, then peripheral vascular diseases (PVDs). The prevalence of cardiovascular diseases (CVDs) is predicted to increase in line with the growing elderly population, which will be advantageous for the industry. A blood ailment called PVD causes arteries and veins outside the brain and heart to narrow due to plaque accumulation following surgery. According to the Centers for Disease Control and Prevention (CDC), PVD affects 12 to 20% of Americans who are 60 years or older in the United States. Because of the growing prevalence of lifestyle problems and increased knowledge of minimally invasive techniques, it is projected that the peripheral diseases market will have significant growth.

Enquiry Before Buying:
https://www.insightaceanalytic.com/enquiry-before-buying/1454

The North American embolic protection devices market holds a significant regional revenue share.
The North American embolic protection devices market is expected to register the highest market share in revenue shortly. Transcatheter aortic valve replacement (TAVR) procedures are becoming more popular in the area, and the number of patients with chronic illnesses is rising. These trends will influence the industry's future. The rise in obesity instances brought on by lifestyle modifications, unhealthy eating habits, and the large concentration of leading industry players in the region are additional factors that will favourably affect North American market statistics.

Additionally, the Asia Pacific is anticipated to expand at a significant rate over the course of the forecast period. The market for embolic protection devices will grow more quickly due to end users being encouraged to use new products and technologically advanced methods. Additional factors fueling the market's growth include rising R&D expenditures, technologically advanced infrastructure in the region, and rising healthcare costs.

Competitive Landscape
Some major key players in the embolic protection devices market are Abbott Laboratories, Allium Medica, Boston Scientific Corporation, Cardinal Health, Contego Medical, LLC, Edwards Lifesciences Corporation, W. L. Gore & Associates (Gore Medical), Innovative Cardiovascular Solutions, LLC, Keystone Heart, Medtronic, Metactive Medical, and Transverse Medical, Inc.

Get Specific Chapter/Information From The Report:
https://www.insightaceanalytic.com/customisation/1454

Segmentation of Embolic Protection Devices Market-
By Product-
• Distal Occlusion Systems
• Distal Filters
• Proximal Occlusion Systems
By Application-
• Neurovascular Disease
• Cardiovascular Disease
• Peripheral Disease
By Material-
• Nitinol
• Polyurethane
By End-Use-
• Ambulatory Surgical Centers
• Hospitals
• Others
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• South East Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of Middle East and Africa

Get More Information:
https://www.insightaceanalytic.com/report/global-embolic-protection-devices-market-/1454

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.https://www.insightaceanalytic.com/images_data/148861653.

Contact Us:
info@insightaceanalytic.com
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 607 400-7072
Asia: +91 79 72967118
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ
Twitter: https://twitter.com/Insightace

This release was published on openPR.